Venetoclax, Obinutuzumab, and Atezolizumab for Richter's Transformation - Dr. Nitin Jain ASH 2021

Venetoclax, Obinutuzumab, and Atezolizumab for Richter's Transformation - Dr. Nitin Jain ASH 2021Подробнее

Evaluating the efficacy of obinutuzumab, ibrutinib, and venetoclax in Richter's transformationПодробнее

Atezolizumab with venetoclax and obinutuzumab in patients with CLLПодробнее

Atezolizumab-obinutuzumab-venetoclax in follicular lymphoma and MZLПодробнее

Inotuzumab ozogamicin & venetoclax in the treatment of B-ALL: findings from a Phase I trialПодробнее

MAJIC: Venetoclax with acalabrutinib or obinutuzumab in CLLПодробнее

Venetoclax plus Chemotherapy for Older Patients with Acute Lymphoblastic Leukemia (ALL)Подробнее

Dr. Jain Discusses Treatment of Richter's Transformation in CLLПодробнее

Treating Richter’s transformation with venetoclax, obinutuzumab and atezolizumabПодробнее

Atezolizumab, Obinutuzumab, and Venetoclax provide durable remissions for untreated DLBCL-RS ptsПодробнее

5-year follow-up results of CLL14: obinutuzumab + venetoclax vs obinutuzumab + chlorambucil in CLLПодробнее

BEAT-SC: Phase III trial of bevacizumab or placebo with atezolizumab & chemo in extensive-stage SCLCПодробнее

What is Venetoclax? | Dana-Farber Cancer InstituteПодробнее

Brian Jonas, ASCO20: Venetoclax combination treatment in older patients with acute myeloid leukemiaПодробнее

Venetoclax and obinutuzumab for CLLПодробнее

The 2008 Nobel Prize in Physiology or Medicine goes to...Подробнее

Venetoclax dose-escalation and obinutuzumab treatment schedule in a clinical trialПодробнее

Venetoclax and obinutuzumab combination therapy for CLLПодробнее

Obinutuzumab plus venetoclax in early R/R DLBCLПодробнее

LYSA: atezolizumab, obinutuzumab and venetoclax in R/R DLBCLПодробнее